Study guide
Melanin, Pigment Conditions, and Suspicious-Lesion Referral
Virginia Master Esthetics License Exam Exam
Track your progress as you read
Finished sections get a check mark.
1 Exam Preparation and Practical Walkthroughs
Current Exam Structure, Scheduling, and a Study Plan Practical Walkthrough: First Client, Cleansing, MLD, Particles, and LED Practical Walkthrough: New Client, Ultrasound, Microcurrent, AHA, Body, and Blood
2 Infection Control and Occupational Safety
Microorganisms, Disease Causes, and Transmission Cleaning, Disinfection, Product Labels, and Tool Storage Sterilization, Monitoring, Packaging, and Sharps OSHA Bloodborne Pathogens and Exposure Response
3 Skin Histology, Barrier, Appendages, and Repair
Epidermal Layers, Cells, Renewal, and Barrier Significance Dermal Organization, Matrix, Vessels, and Sensation Barrier Lipids, Hydration, Acid Mantle, and TEWL Skin Appendages, Secretions, and Wound-Healing Phases
4 Facial Anatomy, Circulation, and Lymphatic Pathways
Facial Expression, Mastication, Cranial Nerves, and Regional Caution Head and Neck Vessels, Filtration, and Referral Concerns Lymphatic Vessels, Nodes, Territories, and Venous Return
5 Skin Findings, Conditions, and Referral
Primary and Secondary Lesion Morphology and Referral Acne Mechanisms, Severity Descriptions, and Cosmetic Decisions Rosacea Features, Historical Subtypes, and Sensitive-Skin Decisions Melanin, Pigment Conditions, and Suspicious-Lesion Referral
6 Cosmetic Chemistry, Ingredients, and Labels
Formulations, pH, pKa, and Acid-Equilibrium Calculations AHA, Salicylic, PHA, Enzyme, and TCA Comparisons Retinoids, Antioxidants, Peptides, and Growth-Factor Claims Delivery Systems, Ingredient Labels, Irritation, and Allergy
7 Consultation, Phototype, Aging, and Skin Observation
Consultation, Medicines, Contraindications, and Consent Fitzpatrick Phototype, Pigment History, and Individual Risk Intrinsic and Extrinsic Aging, Scales, and Examination Tools
8 Chemical Exfoliation: Selection, Endpoints, and Care
Superficial Chemical Exfoliation: Selection and Application Jessner, Modified Jessner, and TCA: Selection and Exposure Peel Endpoints, Surface Residue, Neutralization, and Adverse Events Pre-Peel Care, Recovery Instructions, and Complication Referral
9 Mechanical and Fluid-Assisted Exfoliation
Crystal and Diamond Microdermabrasion: Equipment and Controls Microdermabrasion: Preparation, Technique, and Adverse Responses Dermaplaning Awareness and Blade Safety Hydrodermabrasion and Physical Exfoliation Systems
10 Electrical, Acoustic, RF, and Pressure Devices
Electrical Measurements, Circuits, and Treatment-Room Safety Galvanic Current: Desincrustation and Iontophoresis High Frequency and Ultrasonic Spatulas: Recognition and Safe Use Microcurrent: Units, Evidence, Products, and Applicator Control RF, Device-Assisted Lymphatic Methods, and Product Selection
11 LED, Optical Physics, and Medical Laser Awareness
Light Physics, Spectrum, and Tissue Interactions LED Phototherapy: Selection, Dose, Products, and Protection Laser and IPL Physics: Selectivity and Medical Boundaries Hair Cycles, Laser Reduction, and Eye and Plume Safety
12 Lymphatic Methods and Body Services
Manual Lymphatic Drainage: Movements, Sequence, and Practical Skills MLD Client Selection: Edema, Medical Coordination, and Referral Body Scrubs, Wraps, Cellulite, and Hydrotherapy
13 Current Virginia Licensing, Scope, and Facility Rules
Virginia Licensing Routes, Training, Renewal, and Reinstatement Virginia Scope: Exfoliators, Lasers, and Medical Authority Virginia Sanitation: Tools, Linens, Chemicals, and Blood Spills Virginia Spa, School, Instructor, Records, and Discipline Rules
14 Advanced Therapy and Medical Procedure Awareness
Cryogenic, Ayurvedic, Plant, and Algae Therapy Awareness Medical Aesthetics Vocabulary and Care Coordination Microneedling, Ultrasound, PRP, and PRF Awareness
15 Service Environments, Documentation, and Extractions
Protocols in Clinical, Spa, and Home Environments Protocol Records, Consent, Assessment, and Follow-Up Extractions: Lesion Selection, Implements, and Safe Technique
16 Hair Removal and Aromatherapy
Waxing, Sugaring, Tweezing, and Electrolysis Awareness Hair-Removal Regions, Skin Support, and Client Protection Aromatherapy: Products, Exposure Routes, and Sensory Services
Melanin, Pigment Conditions, and Suspicious-Lesion Referral
Key Takeaways Explain This Topic AI
Pigment changes have multiple causes and cannot be diagnosed from color alone.
PIH can occur across skin tones after inflammation or injury.
ABCDE and change are referral prompts, not diagnostic proof.
Do not cosmetically remove an undiagnosed suspicious lesion or recommend unapproved OTC hydroquinone.
Last updated: October 2026
Biology of Cutaneous Melanogenesis
Melanin synthesis provides the skin's primary physiological photoprotective defense against solar ultraviolet radiation (UVR). In advanced master esthetics, understanding melanogenesis is crucial for managing hyperpigmentation, predicting responses across Fitzpatrick phototypes, and preventing post-inflammatory complications.
The Enzymatic Pathway of Melanin Synthesis
Melanocytes are specialized, dendritic, neural crest-derived cells located in the stratum basale of the epidermis, distributed among keratinocytes in a ratio of approximately 1 melanocyte to 10–36 keratinocytes (the epidermal-melanin unit).
The Rate-Limiting Enzyme: Melanogenesis takes place within membrane-bound organelles called melanosomes , governed by the copper-dependent enzyme tyrosinase .
The Cascade:
Tyrosinase converts L-tyrosine to L-DOPA (L-3,4-dihydroxyphenylalanine).
Tyrosinase oxidizes L-DOPA to dopaquinone .
Divergence:
Eumelanin Pathway: Dopaquinone cyclizes into dopachrome, forming DHI and DHICA, which polymerize into eumelanin —an insoluble brown-black pigment that absorbs UV, dissipates heat, and scavenges free radicals.
Pheomelanin Pathway: In the presence of cysteine, dopaquinone binds cysteine to form cysteinyl-DOPA, polymerizing into pheomelanin —a yellow-red pigment that offers poor photoprotection and generates reactive oxygen species (ROS) upon UV exposure.
Melanosome Transfer: Melanosomes mature (Stages I–IV) and reach keratinocytes through transfer processes that remain under investigation, including uptake of pigment material, forming a supranuclear "cap" shielding nuclear DNA from UV damage.
Pigment patterns and limitations of observation
Hyperpigmentation means increased visible pigment; hypopigmentation means reduced pigment. Post-inflammatory hyperpigmentation can follow irritation or injury, including cosmetic procedures. It can occur across skin tones, though susceptibility and persistence vary. Avoid producing inflammation in order to treat a color change aggressively.
Melasma is a medical pigment condition with multiple influences. Lentigines, freckles, and other pigmented findings have different clinical contexts. An esthetician should not assume every brown spot is one of them or remove a spot before it is assessed. New, changing, asymmetrical, or bleeding pigment is a referral concern.
Vitiligo and albinism are distinct conditions. Albinism includes heterogeneous inherited disorders affecting melanin production; it is not universally complete absence of tyrosinase in every person. Reduced pigmentation can also arise after injury or disease. Record the actual history and medical diagnosis if available rather than classifying every pale patch as vitiligo.
Wood's-lamp findings can support aspects of clinical examination under appropriate conditions, but do not prove pigment depth in every skin tone or formulation. Cosmetics and other substances can affect fluorescence. Do not select a deeper peel merely because a spot does not appear to enhance under a lamp.
- Observation Safe interpretation
- Pigment after prior inflammation PIH is a possibility; history and assessment matter
- Symmetrical facial patches Several causes remain possible
- Reduced pigment Does not by itself identify an inherited or autoimmune cause
- Changing isolated spot Needs appropriate evaluation before cosmetic treatment
- Lamp fluorescence An observation with limitations, not a tissue-depth measurement
Prescription pigment treatment belongs to an authorized prescriber. Hydroquinone-containing skin-lightening products are not approved for OTC sale in the United States; do not recommend an unapproved OTC hydroquinone product as mandatory priming. Suitable cosmetic ingredients and sun protection must still fit the client's actual condition and routine.
Recognize the need for medical evaluation
Actinic keratoses are medically assessed sun-related lesions with potential significance. Basal-cell carcinoma, squamous-cell carcinoma, and melanoma have different origins and appearances, and no cosmetic checklist reliably rules them out. Do not use one universal percentage to predict progression of every actinic lesion.
A nonhealing, recurrently crusted, changing, bleeding, or unusual spot should be referred. Avoid exfoliating, extracting, freezing, or applying a laser to an undiagnosed lesion. Such treatment can injure tissue and delay or obscure diagnosis. It is inaccurate to say that peeling necessarily pushes malignant cells deeper into skin.
ABCDE, change, and the ugly-duckling concept
ABCDE is a public recognition aid: asymmetry, irregular border, varied color, diameter, and evolution. A diameter over six millimeters can be concerning, but melanoma can be smaller. Evolution includes change in size, shape, color, symptoms, or behavior. A spot unlike the person's others is sometimes described as an ugly duckling.
These are warning prompts, not definitive diagnostic criteria. Some cancers do not follow a simple visual pattern. The absence of every ABCDE feature does not certify a lesion as safe for treatment. Ask about change and prior evaluation, record observations, and recommend medical assessment when concerned.
Sun protection includes appropriate broad-spectrum sunscreen, shade, clothing, and avoiding deliberate tanning. Pigmented skin can still burn and develop skin cancer. Cosmetic tone-evening should not distract from a changing lesion or imply that sunscreen removes all risk.
A client asks to peel a dark spot that has grown and begun bleeding. Defer treatment of the spot and recommend prompt dermatologic assessment. Do not test it with abrasion or promise that pigment inhibitors will make it disappear. The appropriate action follows the reported evolution and symptoms, without the esthetician needing to name the cancer.
For the exam, distinguish melanin physiology from disease diagnosis and cosmetic product selection. Melanocytes synthesize pigment and transfer melanosomes to keratinocytes, but a visible patch does not reveal the exact number of cells, enzyme activity, or tissue depth. Medical evaluation and lawful cosmetic planning remain separate decisions.
Sources and current rules
FDA OTC hydroquinone warning ; AAD skin-cancer recognition . Checked October 7, 2026.